| Document |
Document Title |
|
WO/2024/077193A2 |
The invention relates to microbials for use in improving the health of a human and animals. More particularly, the invention relates to isolated Bacillus strains, and strains having all of the identifying characteristics of these strains...
|
|
WO/2024/075780A1 |
Provided is a method for stably mass culturing Dehalococcoides genus bacteria using a keg-like metal pressure-resistant culture vessel. This method for culturing Dehalococcoides genus bacteria uses a metal pressure-resistant culture ve...
|
|
WO/2024/076047A1 |
The present invention relates to: a Streptomyces lydicus JCK-6019 strain having excellent antifungal activity and, at the same time, being capable of inducing resistance in a treated plant; a composition for plant disease control compris...
|
|
WO/2024/077181A1 |
Provided are isolated strains of Lactobacillus reuteri, their use in methods of producing 3-hydroxypropanal (reuterin) and/or propenoic acid that involves culturing the isolated strain in a growth medium and a production medium, along wi...
|
|
WO/2024/076308A1 |
The present disclosure relates to a microbial consortium for plant growth and a method for preparing the microbial consortium The microbial consortium comprises at least two microbial strains, wherein each of the at least two microbial s...
|
|
WO/2024/071109A1 |
The purpose of the present invention is to simplify a cell culture device. The present invention relates to a cell culture device (100) for culturing cells, the cell culture device being equipped with: a culture tank (1) for pooling a cu...
|
|
WO/2024/066822A1 |
The present invention provides a method for producing γ-butyrolactone or 1,4-butanediol by fermentation. By means of a synthetic biology technique, Corynebacterium glutamicum is taken as a chassis, and an exogenous glutamate decarboxyla...
|
|
WO/2024/068640A1 |
A method for producing fungal spores, wherein the fungal spores are grown in a first liquid medium and then in a second liquid medium, the first liquid medium having a lower carbon content than the second liquid medium.
|
|
WO/2024/065008A1 |
The present invention relates to a method for harvesting microalgae, the method comprising (i) mixing one or more monomers, a photoinitiator, water and a deoxygenation system to form a mixture; (ii) exposing the mixture to UV light so as...
|
|
WO/2024/071397A1 |
The present invention provides an IL13RA2-targeting herpes simplex virus in which an anti-IL13RA2 antibody or an antigen-binding fragment thereof is presented on the viral surface. Also provided is an anti-IL13RA2 antibody or an antigen-...
|
|
WO/2024/071336A1 |
The present invention relates to a bacterial exopolysaccharide having a repeating structure comprising a series of repeating units represented by formula (I), and to the use of the bacterial exopolysaccharide for immunopotentiation. (In ...
|
|
WO/2024/071736A1 |
An aspect of the present invention relates to a pharmaceutical composition for the prevention or treatment of allergic diseases, containing dead cells of Streptococcus pyogenes or Streptococcal pyrogenic Exotoxin A (SpeA) protein. The de...
|
|
WO/2024/066819A1 |
Disclosed is a method for producing 3-hydroxypropionic acid and acrylic acid by means of fermentation. The present invention provides a recombinant Corynebacterium glutamicum. The aldehyde dehydrogenase gene ald of the microorganism is u...
|
|
WO/2024/067386A1 |
The present invention provides a culture medium and use thereof in water toxicity colorimetric detection. The culture medium comprises glucose, peptone, NaCl, a beef extract, and a ferric salt. The solubility of the ferric salt in water ...
|
|
WO/2024/073063A1 |
Described herein is a method of diagnosing Lyme disease in a subject. The method includes determining a glycosylation profile of a protein whose glycosylation profile is associated with Lyme disease in a subject, and comparing the glycos...
|
|
WO/2024/071279A1 |
Provided is a super-high-molecular gamma-polyglutamic acid having an average molecular weight of at least 20 million. Also provided is a Bacillus genus bacterium variant strain that can produce said super-high-molecular γ-PGA. Further p...
|
|
WO/2024/067747A1 |
The present invention provides a 5'-UTR sequence capable of improving the translation efficiency of a protein coding region, and a use thereof. The 5'-UTR sequence of the present invention can improve the translation efficiency of the pr...
|
|
WO/2024/066079A1 |
The present invention provides a bile acid metabolizing bacterium for preventing and treating an inflammatory bowel disease and use thereof. The present invention provides a bacterium which comprises any one, two or three of the followin...
|
|
WO/2024/067086A1 |
Provided is a Bacillus licheniformis cell capable of being stably and repeatedly used for conversion and synthesis of D-allulose, which belongs to the field of biotechnology. D-allulose is a functional sugar with a high health value and ...
|
|
WO/2024/067591A1 |
Provided are a Collinsella aerofaciens capable of regulating an autoimmune response and use thereof in the field of immunotherapy of inflammatory bowel disease. By enhancing the differentiation of Treg cells, the Collinsella aerofaciens ...
|
|
WO/2024/070185A1 |
[Problem] To provide a biomarker which is usable for determining the onset risk of acne. [Solution] One aspect of the present invention provides a biomarker which is usable for determining the onset risk of acne. The biomarker is type II...
|
|
WO/2024/073719A2 |
Bacillus strain compositions and methods for reducing growth of one or more mastitis-causing organisms and/or reducing a symptom, sign, or occurrence of mastitis in animals are provided. The Bacillus strain composition can comprise a bac...
|
|
WO/2024/065274A1 |
Provided is a method against Salmonella typhimurium infection using a composition containing cultures of Lactobacillus rhamnosus LRH10 which is deposited at the Deutsche Sammlung Von Mikroorganismen und Zellkulturen (DSMZ) GmbH under an ...
|
|
WO/2024/068637A1 |
The present invention relates to a method of culturing Lawsonia intracellularis. To obtain a more stable and constant production yield, McCoy cells are infected with Lawsonia intracellularis bacteria, grown in a first growth medium at a ...
|
|
WO/2024/067354A1 |
Provided are a magnetic bead removing method and device and a storage medium. The method comprises: placing a liquid bag having a curved flow channel on a magnetic platform, a plane where the curved flow channel is arranged being located...
|
|
WO/2024/066434A1 |
Disclosed in the invention are an Akkermania and a product and use thereof. The Akkermania is Akkermansia guangxiensis N21116 and N21169, and the accession numbers are respectively: GDMCC No: 62888 and GDMCC No: 62889. Akkermansia guangx...
|
|
WO/2024/070193A1 |
The present invention provides a material that can suppress the occurrence of unevenness in a growth-promoting effect of plants, and that includes a culture medium of xsd08001 strain of the Cephaliophora sp. genus, with a cumulative 50% ...
|
|
WO/2024/067774A1 |
The present invention relates to saccharomyces cerevisiae engineering bacteria for improving a gene expression level and a construction method and application thereof. The saccharomyces cerevisiae W303-1a is used as an original strain. A...
|
|
WO/2024/069618A2 |
The present invention relates to methods and/or substrates for inducing and growing fungi of the genus Laetiporus, including Laetiporus sulphureus. Fruiting in the methods of the present invention is induced by a decrease in the CO2 conc...
|
|
WO/2024/068429A1 |
The present invention is in the field of food technology. It relates to methods for producing coffee beans, coffee beverages and coffee-based products, characterized in that at fermentation is carried out by inoculating coffee cherries w...
|
|
WO/2024/068943A1 |
The invention refers to a method for the production of microbial biocapsules comprising: (a) cultivating the filamentous fungus by vortex agitation and sonication, followed by inoculation and incubation, obtaining cultured filamentous fu...
|
|
WO/2024/068620A1 |
The present invention relates to a method for reducing asperphenamate concentration in a nutritional composition comprising asperphenamate, the method comprising the step of providing a microorganism comprising a polynucleotide having at...
|
|
WO/2024/065035A1 |
Compositions and processes for fabricating sorption units or filter units containing sorbent materials, for example activated carbon or charcoal powders, are disclosed. The sorbents are embedded within a porous matrix. In some examples, ...
|
|
WO/2024/071134A1 |
The present invention addresses the problem of providing a mutant of a cyanobacterium having predation resistance. This problem is solved by a mutant of a cyanobacterium in which the function of the spoIID gene is reduced or defective co...
|
|
WO/2024/070494A1 |
The present invention provides: a method for producing pancreatic endoderm cells, the method comprising a step for culturing pancreatic endoderm cells in a culture medium containing a ROCK inhibitor and KGF and/or EGF; and pancreatic end...
|
|
WO/2024/072098A1 |
Based on purpose of use of mycelium, status of raw material inventory and supply and demand, operational status and operation plans of production facilities, etc., a technique to automatically determine an optimal culture method for prod...
|
|
WO/2024/071043A1 |
Provided is a novel production method of a hetero that enables the production of a heteromultimeric protein such as a bispecific antibody. The production method of the present disclosure, which is for producing a heteromultimeric prote...
|
|
WO/2024/064079A1 |
Cells may be grown in a bioreactor, and the cells may be activated by an activator (e.g., a soluble activator complex). Nutrient and gas exchange capabilities of a closed, automated cell expansion system may allow cells to be seeded at r...
|
|
WO/2024/062136A1 |
The present invention relates to a method for the preparation of a mycelium colonized substrate. The present invention further relates to an intermediate product in the preparation of a mycelium colonized substrate, comprising mycelium c...
|
|
WO/2024/063050A1 |
Provided is a lipase variant having improved heterologous expression properties. This lipase variant comprises an amino acid sequence in which, in comparison to the amino acid sequence of the parent lipase, an amino acid residue that is ...
|
|
WO/2024/064888A2 |
The present disclosure provides materials and methods related to the production of peptides and polypeptides from engineered microorganisms. In particular, the present disclosure provides compositions and methods for producing a genetica...
|
|
WO/2024/060950A1 |
The present invention relates to the field of gene technology for disease prevention and control. The present invention provides a method for preparing a biocontrol engineering microorganism using Trichoderma harzianum as a dsRNA vector....
|
|
WO/2024/062992A1 |
A DNA sequence screening method of the present invention comprises at least: (a) a step for preparing a plasmid that contains a plurality of DNA fragments encoding a multi-modular biosynthetic enzyme by accumulating DNA fragments using t...
|
|
WO/2024/063737A1 |
Although this invention is primarily designed for various types of bone defects in dentistry, it can also be used in the medical field for various types of bone defects. It can be used in maxillary sinus augmentations, various intraosseo...
|
|
WO/2024/060516A1 |
Provided is a method for preparing a live microorganism-based composite biological material for repairing a Cr(VI)-polluted water body, comprising: using a modified melamine sponge as a composite material support for fixing live microorg...
|
|
WO/2024/060768A1 |
The present application relates to the field of microorganisms, and in particular to, a breast milk-derived Lactobacillus plantarum strain HM-P2, a microbial agent comprising same, a composition comprising same, and use thereof. The L. p...
|
|
WO/2024/059914A1 |
A process is disclosed for producing an absorbent for absorption of hydrocarbon-based and aqueous-based contamination. The process comprises providing acidified cotton dust. The acidified cotton dust is typically a waste product from the...
|
|
WO/2024/061158A1 |
The antibodies bind to SLIT2 and related substitution mutants, including their manufacture and use.
|
|
WO/2024/062322A1 |
Exemplary embodiments of the present disclosure are directed towards a method for identifying, isolating and authentication of host specific Rhizobium species a nitrogen fixing bacteria. The Rhizobium species in the present disclosure is...
|
|
WO/2024/064957A2 |
Disclosed herein are components, kits, platforms, and systems for novel, bacterial-based, cell-free glycosylation for incorporating non-canonical sugars and constructing azido-sialoglycoprotein structures.
|
